Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 4 1Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 4Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Agnosia 2Acute Pain 2Rectal Neoplasms 1Prostatic Neoplasms 1Otolaryngeal Cancer 1Lymphoma, Follicular 1Ileus 1Gastrointestinal Neoplasms 1Emergence Delirium 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 2Oxygen 1Nitrous Oxide 1Music Therapy 1Midazolam 1Ketamine 1Hepatitis B Vaccines 1Gabapentin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anxiety Disorders × Ketamine × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡